포스트 코로나 신종감염병: 다음 대유행의 주인공은 누구인가?
Post COVID-19 Emerging Infectious Diseases: What is the Next Pandemic Agent?
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Emerging infectious diseases are increasing recently and globally. We have a long list of infectious disease epidemic in the 21th century followed by SARS, MERS, Ebola virus disease, and Zika virus infection. COVID-19 is a still ongoing pandemic. What will be the next pandemic agent? The World Health Organization proposed a research and development blueprint regarding global pandemic in 2016. The United Kingdom maintains a list of high consequence infectious diseases and is monitoring them. The Republic of Korea designates Class 1 infectious diseases capable of causing outbreak or epidemic. This article briefly describes several infectious diseases and its causative pathogen that should receive special attention.
Abstract
Emerging infectious diseases are increasing recently and globally. We have a long list of infectious disease epidemic in the 21th century followed by SARS, MERS, Ebola virus disease, and Zika virus infection. COVID-19 is a still ongoing pandemic. What will be the next pandemic agent? The World Health Organization proposed a research and development blueprint regarding global pandemic in 2016. The United Kingdom maintains a list of high consequence infectious diseases and is monitoring them. The Republic of Korea designates Class 1 infectious diseases capable of causing outbreak or epidemic. This article briefly describes several infectious diseases and its causative pathogen that should receive special attention.
참고문헌 (18)
- Morse SS, "Factors in the emergence of infectious diseases", Emerg Infect Dis, 1, pp.7~15 (1995)
- Morens DM, "The challenge of emerging and re-emerging infectious diseases", Nature, 430, pp.242~249 (2004)
- Jones KE, "Global trends in emerging infectious diseases", Nature, 451, pp.990~993 (2008)
- Wolfe ND, "Origins of major human infectious diseases", Nature, 447, pp.279~283 (2007)
- Mehand MS, "The WHO R&D Blueprint : 2018 review of emerging infectious diseases requiring urgent research and development efforts", Antiviral Res, 159, pp.63~67 (2018)
- Weber DJ, "Emerging infectious diseases: focus on infection control issues for novel coronaviruses (severe acute respiratory syndrome-CoV and Middle East respiratory syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)", Am J Infect Control, 44(Suppl 5), pp.e91~e100 (2016)
- Wright D, "Rift Valley fever : biology and epidemiology", J Gen Virol, 100, pp.1187~1199 (2019)
- Fillâtre P, "Crimean-Congo hemorrhagic fever : an update", Med Mal Infect, 49, pp.574~585 (2019)
- Ferraris P, "Zika virus infection : an update", Microbes Infect, 21, pp.353~360 (2019)
- Kortepeter MG, "Marburg virus disease : A summary for clinicians", Int J Infect Dis, 99, pp.233~242 (2020)
- Asogun DA, "Lassa fever : epidemiology, clinical features, diagnosis, management and prevention", Infect Dis Clin North Am, 33, pp.933~951 (2019)
- Malvy D, "Ebola virus disease", Lancet, 393, pp.936~948 (2019)
- Hauser N, "Evolution of Nipah virus infection : past, present, and future considerations", Trop Med Infect Dis, 6, pp.24~ (2021)
- Kirtipal N, "From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses", Infect Genet Evol, 85, pp.104502~ (2020)
- Al-Tawfiq JA, "Middle East respiratory syndrome coronavirus", Semin Respir Crit Care Med, 42, pp.828~838 (2021)
- 최원석, "Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea", Infection and Chemotherapy, 48(2), pp.118~126 (2016), 대한감염학회
- "Infectious Disease Control and Prevention Act" (2019)[URL]
- "High consequence infectious diseases (HCID)" (2022)[URL]